Cargando…
The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus
The expansion of the therapeutic armamentarium available to oncologists and haematologists has led to a significant improvement in cancer survival; however, many of the available treatments carry a risk of toxicity to the heart. Cardio-oncology has emerged as a rapidly developing subspeciality dedic...
Autores principales: | Gent, David G, Rebecca, Dobson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316349/ https://www.ncbi.nlm.nih.gov/pubmed/37405348 http://dx.doi.org/10.15420/ecr.2022.63 |
Ejemplares similares
-
Cardio-oncology in 2022
por: Dobson, Rebecca
Publicado: (2023) -
Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021) -
Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020) -
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
por: de Boer, Rudolf A., et al.
Publicado: (2020) -
Cardio‐Oncology at the Beginning of a New Decade
por: Grumbach, Isabella M.
Publicado: (2020)